Authors:
WINKELSTEIN JA
MARINO K
JOHNSTON RB
BOYLE J
BUCKLEY RH
CHANOCK S
CURNUTTE JT
FOSTER C
GALLIN JI
HOLLAND SM
MALECH HL
OCHS HD
QUIE P
DICKLER H
Citation: Ja. Winkelstein et al., CHRONIC GRANULOMATOUS-DISEASE - REPORT ON A REGISTRY OF 368 PATIENTS, Molecular immunology, 35(11-12), 1998, pp. 795-795
Authors:
WALSH TJ
YELDANDI V
MCEVOY M
GONZALEZ C
CHANOCK S
FREIFELD A
SEIBEL NI
WHITCOMB PO
JAROSINSKI P
BOSWELL G
BEKERSKY I
ALAK A
BUELL D
BARRET J
WILSON W
Citation: Tj. Walsh et al., SAFETY, TOLERANCE, AND PHARMACOKINETICS OF A SMALL UNILAMELLAR LIPOSOMAL FORMULATION OF AMPHOTERICIN-B (AMBISOME) IN NEUTROPENIC PATIENTS, Antimicrobial agents and chemotherapy, 42(9), 1998, pp. 2391-2398
Authors:
WANG YH
RUSSO TA
KWON O
CHANOCK S
RUMSEY SC
LEVINE M
Citation: Yh. Wang et al., ASCORBATE RECYCLING IN HUMAN NEUTROPHILS - INDUCTION BY BACTERIA, Proceedings of the National Academy of Sciences of the United Statesof America, 94(25), 1997, pp. 13816-13819
Authors:
ROILIDES E
SEIN T
HOLMES A
CHANOCK S
BLAKE C
PIZZO PA
WALSH TJ
Citation: E. Roilides et al., EFFECTS OF MACROPHAGE-COLONY-STIMULATING FACTOR ON ANTIFUNGAL ACTIVITY OF MONONUCLEAR PHAGOCYTES AGAINST ASPERGILLUS-FUMIGATUS, The Journal of infectious diseases, 172(4), 1995, pp. 1028-1034
Citation: Rj. Simonds et S. Chanock, MEDICAL ISSUES RELATED TO CARING FOR HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN IN AND OUT OF THE HOME, The Pediatric infectious disease journal, 12(10), 1993, pp. 845-852
Citation: S. Chanock, EVOLVING RISK-FACTORS FOR INFECTIOUS COMPLICATIONS OF CANCER-THERAPY, Hematology/oncology clinics of North America, 7(4), 1993, pp. 771-793